The 11th annual BIO-Europe Spring conference is just around the corner. The Pharma Intelligence team has several exciting activities lined up and we hope to see you there.
Spotlight panel discussion: Key considerations in microbiome partnering
Monday, 20 March 2017 16:00 - 17:00
Location: Level 1, Room 123
Moderator: Mike Ward, Global Content Director, Informa Pharma Insights
Panelists: Michel de Baar, Executive Director, BD&L, Infectious Diseases & Vaccines, Cardiovascular & Metabolic Diseases at MSD; Eric de la Fortelle, Venture Partner at Seventure; Mariona Serra-Pagès, CEO at Goodgut
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures. Join this panel to hear how emerging microbiome companies identify their preferred partners and what pharma companies and funders are able to bring to the table.
Tuesday, 21 March, 17.45-18.45
Pharma Intelligence’s business development and licensing solutions provide the actionable intelligence you need to optimize your partnership strategy. Stop by our booth to learn more.
Industry experts Lucie Ellis and Mike Ward will be available on Tuesday and Wednesday to conduct interviews. This year we are looking to hear from companies within the Biosimilars or MicroBiome development area as well as biotech starts ups.